ARROWHEAD PHARMACEUTICALS, INC. - 10-K Filing
Arrowhead Pharmaceuticals reports fiscal year 2026 financial position and details extensive collaboration agreements with Sarepta, Novartis, Sanofi, and GSK.
Tickers: $ARWR
Arrowhead Pharmaceuticals reports fiscal year 2026 financial position and details extensive collaboration agreements with Sarepta, Novartis, Sanofi, and GSK.
Tickers: $ARWR